Evaluating Human-Specific Immunotherapeutics Using HSC and PBMC Humanized Models
These will fill an extremely promising niche in human-specific immunotherapeutics of diseases such as cancer, autoimmune disease, or infections. The process of obtaining these preclinical models, however is not very…
